AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28642210 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75mg + PPI for 1 year
Number of subjects: 1560
Study 25990828 — intervention group
Group type: EXPERIMENTAL
Intervention: High molecular weight sodium hyaluronate (SH) at a dosage of 9 mg three times a day for 30 days
Number of subjects: 20
Study 25990828 — intervention group
Group type: COMPARATOR
Intervention: Control group (B)
Number of subjects: 20
Study 23683447 — intervention group
Group type: EXPERIMENTAL
Intervention: 40mL of 0.5% lidocaine alone (n=30)
Number of subjects: 60
Study 23683447 — intervention group
Group type: COMPARATOR
Intervention: Combination of 40mL of 0.25% lidocaine with 0.05mg fentanyl and 0.5mg vecuronium (n=30)
Number of subjects: 60
Study 21159683 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 μg misoprostol administered 3 hours prior to IUD insertion
Number of subjects: 270
Study 21159683 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered 3 hours prior to IUD insertion
Number of subjects: 270
Study 21159683 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 μg misoprostol
Number of subjects: 270
Study 21159683 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 19002702 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (BUP) 300 mg for 7 days after 150 mg for 3 days
Number of subjects: 8
Study 19002702 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 8
Study 17701883 — intervention group
Group type: EXPERIMENTAL
Intervention: Propylthiouracil (6-8 mg/kg/day)
Number of subjects: 44
Study 17701883 — intervention group
Group type: COMPARATOR
Intervention: Control (euthyroid healthy subjects)
Number of subjects: 44
Study 15651715 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (1 MAC in a 50% O2/N2O mixture)
Number of subjects: 60
Study 15651715 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (8 mg/kg for the first 30 min, followed by 6 mg/kg for maintenance in a 50% O2/N2O mixture)
Number of subjects: 60
Study 15651715 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (1 MAC in a 50% O2/N2O mixture)
Number of subjects: 60
Study 11982870 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine
Number of subjects: 86
Study 11982870 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vaccine)
Number of subjects: 86
Study 10063490 — intervention group
Group type: EXPERIMENTAL
Intervention: mecamylamine (2.5 mg tablet)
Number of subjects: 23
Study 10063490 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 23
Study 7586109 — intervention group
Group type: EXPERIMENTAL
Intervention: 22-gauge Sprotte needle (directional, Group 2)
Number of subjects: 42
Study 7586109 — intervention group
Group type: COMPARATOR
Intervention: 22-gauge Quincke needle (non-directional, Group 1)
Number of subjects: 42
Study 2180995 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% and 3% topical minoxidil
Number of subjects: 31
Study 759879 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillamine (600 to 900 mg)
Number of subjects: 28
Study 759879 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 30891960 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivotal Response Intervention for Social Motivation (PRISM)
Number of subjects: 28
Study 30891960 — intervention group
Group type: COMPARATOR
Intervention: community treatment as usual (TAU)
Number of subjects: 28
Study 30891960 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye tracking (social preference paradigm)
Number of subjects: 28
Study 30891960 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye tracking (face scanning)
Number of subjects: 28
Study 28719683 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Physical Activity
Number of subjects: 0
Study 28719683 — intervention group
Group type: COMPARATOR
Intervention: Control (Sedentary Lifestyle)
Number of subjects: 0
Study 26026485 — intervention group
Group type: EXPERIMENTAL
Intervention: 8Gy radiotherapy
Number of subjects: 651
Study 26026485 — intervention group
Group type: COMPARATOR
Intervention: 4Gy radiotherapy
Number of subjects: 651
Study 23506510 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session brief motivational enhancement (BME) interview
Number of subjects: 82
Study 23506510 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 82
Study 21219984 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP‐IPV//PRP‐T combined vaccine (Pentaxim(®))
Number of subjects: 792
Study 21219984 — intervention group
Group type: COMPARATOR
Intervention: Individual vaccines (DTaP, PRP‐T, IPV)
Number of subjects: 792
Study 19320245 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (300 mg twice daily) from 28 weeks of gestational age to delivery
Number of subjects: 0
Study 16626956 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (12 microg delivered via Modulite b.i.d.)
Number of subjects: 21
Study 16626956 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (18 microg dry powder capsules delivered via HandiHaler once daily)
Number of subjects: 21
Study 16626956 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Formoterol and Tiotropium
Number of subjects: 21
Study 16626956 — intervention group
Group type: COMPARATOR
Intervention: Formoterol alone
Number of subjects: 21
Study 16626956 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium alone
Number of subjects: 21
Study 16626956 — intervention group
Group type: COMPARATOR
Intervention: All treatments (Formoterol, Tiotropium, Combination)
Number of subjects: 21
Study 14517774 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily rhGH therapy (D)
Number of subjects: 20
Study 14517774 — intervention group
Group type: COMPARATOR
Intervention: Alternate-day rhGH therapy (A)
Number of subjects: 20
Study 10882958 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole and antibiotics for H pylori eradication
Number of subjects: 64
Study 10882958 — intervention group
Group type: COMPARATOR
Intervention: Untreated group (control)
Number of subjects: 64
Study 8882989 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (CDDP) 60 mg/m2, Carboplatin (CBDCA) 200 mg/m2, Etoposide (VP-16) 100 mg/m2 (Step 2)
Number of subjects: 36
Study 8882989 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (CDDP) 60 mg/m2, Carboplatin (CBDCA) 250 mg/m2, Etoposide (VP-16) 100 mg/m2 (Step 3)
Number of subjects: 36
Study 1373366 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS (15 daily 60 min treatments over 3 weeks)
Number of subjects: 0
Study 1373366 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 0
Study 2994990 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0
Study 2994990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30835327 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ10 300 mg daily
Number of subjects: 0
Study 30835327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30587642 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 IU Vitamin D3
Number of subjects: 216
Study 30587642 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU Vitamin D3
Number of subjects: 216
Study 30587642 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU Vitamin D3
Number of subjects: 216
Study 27406063 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Ethical Assessment (REA)
Number of subjects: 300
Study 27406063 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 24912581 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonated water
Number of subjects: 467
Study 24912581 — intervention group
Group type: COMPARATOR
Intervention: Still water
Number of subjects: 467
Study 22994410 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual pain coach
Number of subjects: 18
Study 22994410 — intervention group
Group type: COMPARATOR
Intervention: Pain communication education only
Number of subjects: 18
Study 20575111 — intervention group
Group type: EXPERIMENTAL
Intervention: Purse-string closure
Number of subjects: 61
Study 20575111 — intervention group
Group type: COMPARATOR
Intervention: Conventional closure
Number of subjects: 61
Study 18717144 — intervention group
Group type: EXPERIMENTAL
Intervention: CHAMPSA intervention
Number of subjects: 579
Study 18717144 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 579
Study 15987228 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable maintenance dosing (one inhalation twice daily, stepping up to four inhalations twice daily for 1 week if asthma worsened)
Number of subjects: 3297
Study 15987228 — intervention group
Group type: COMPARATOR
Intervention: Fixed dosing (two inhalations twice daily)
Number of subjects: 3297
Study 12826844 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.075, 0.15, 0.3, and 0.6 ng/mL)
Number of subjects: 0
Study 12826844 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 0
Study 12826844 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.15, 0.3, and 0.6 ng/mL)
Number of subjects: 0
Study 10469307 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity laser therapy (wavelength 690 nm, intensity: 80 mW per cm2, dose: 48 J per cm2)
Number of subjects: 50
Study 10469307 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham-irradiation)
Number of subjects: 50
Study 8708523 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lidocaine (50 mg)
Number of subjects: 20
Study 8708523 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nifedipine (10 mg)
Number of subjects: 20
Study 1789830 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rehydration therapy (by mouth or nasogastric tube)
Number of subjects: 111
Study 1789830 — intervention group
Group type: COMPARATOR
Intervention: Intravenous rehydration therapy
Number of subjects: 111
Study 6308488 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide, 50 mg p.d.
Number of subjects: 6
Study 6308488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30161206 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconception micronutrient supplementation
Number of subjects: 1409
Study 26691105 — intervention group
Group type: EXPERIMENTAL
Intervention: Group prenatal care (CenteringPregnancy Plus)
Number of subjects: 1148
Study 24240647 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized, moderate-intensity, 12-week home-based exercise program with weekly telephone support from a certified exercise physiologist
Number of subjects: 40
Study 22339661 — intervention group
Group type: EXPERIMENTAL
Intervention: MVP function programmed [On]
Number of subjects: 220
Study 22339661 — intervention group
Group type: COMPARATOR
Intervention: MVP function programmed [off]
Number of subjects: 220
Study 20150520 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren
Number of subjects: 2327
Study 18579630 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to the Hearts of Salford health portal
Number of subjects: 108
Study 18579630 — intervention group
Group type: COMPARATOR
Intervention: Control group (no access to the health portal)
Number of subjects: 108
Study 15741848 — intervention group
Group type: EXPERIMENTAL
Intervention: LEAP intervention (Lifestyle Education for Activity Program)
Number of subjects: 2087
Study 15741848 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2087
Study 12186232 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable practice conditions (three different types)
Number of subjects: 94
Study 12186232 — intervention group
Group type: COMPARATOR
Intervention: Constant practice condition
Number of subjects: 94
Study 10100043 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrophosphate dentifrice
Number of subjects: 0
Study 10100043 — intervention group
Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 0
Study 7772916 — intervention group
Group type: EXPERIMENTAL
Intervention: Left intraatrial infusion of prostaglandin E1 (PGE1) at 0.003 microgram/kg/min
Number of subjects: 30
Study 7772916 — intervention group
Group type: EXPERIMENTAL
Intervention: Right intraatrial infusion of prostaglandin E1 (PGE1) at 0.03 microgram/kg/min
Number of subjects: 30
Study 7772916 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control group)
Number of subjects: 30
Study 2279574 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative central haemodynamic monitoring in 21 patients
Number of subjects: 40
Study 2279574 — intervention group
Group type: COMPARATOR
Intervention: Central venous pressure monitoring alone in 19 patients
Number of subjects: 40
Study 2279574 — intervention group
Group type: EXPERIMENTAL
Intervention: High risk group (LVEF less than 0.50)
Number of subjects: 40
Study 7017680 — intervention group
Group type: EXPERIMENTAL
Intervention: ATG (added to azathioprine and prednisolone)
Number of subjects: 65
Study 7017680 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAI drugs (replacing steroids)
Number of subjects: 65
Study 7017680 — intervention group
Group type: COMPARATOR
Intervention: Control group (azathioprine and prednisolone without ATG)
Number of subjects: 65
Study 7017680 — intervention group
Group type: COMPARATOR
Intervention: Control group (steroids)
Number of subjects: 65
Study 7017680 — intervention group
Group type: EXPERIMENTAL
Intervention: ATG group
Number of subjects: 65
Study 31136093 — intervention group
Group type: EXPERIMENTAL
Intervention: Congenital blindness
Number of subjects: 3138
Study 31136093 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal hearing and vision)
Number of subjects: 3138
Study 27339805 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based educational programme
Number of subjects: 226
Study 27339805 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 226
Study 25869024 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block (SCPB) with 0.25% bupivacaine, 10 mL
Number of subjects: 46
Study 25869024 — intervention group
Group type: COMPARATOR
Intervention: No Block
Number of subjects: 46
Study 25869024 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block (SCPB)
Number of subjects: 46
Study 23996765 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion at 0.5 µg·kg(‐1)·h(‐1)
Number of subjects: 60
Study 23996765 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline infusion
Number of subjects: 60
Study 21337541 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-L-cysteine (NAC) 100 mg/kg/day
Number of subjects: 160
Study 21337541 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-L-cysteine (NAC) moderate levels (0.4-3.2 mM)
Number of subjects: 160
Study 21337541 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-L-cysteine (NAC) high concentrations (12.5-50 mM)
Number of subjects: 160
Study 21337541 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NAC)
Number of subjects: 160
Study 19675503 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (3 sets of 15RM with 60-second rest between sets and exercises)
Number of subjects: 19
Study 19675503 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 19
Study 19675503 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 19
Study 18091655 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative surgery with sentinel node biopsy
Number of subjects: 0
Study 18091655 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial breast irradiation
Number of subjects: 0
Study 15129994 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% (w/w) urea in semi-solid emulsions
Number of subjects: 0
Study 15129994 — intervention group
Group type: COMPARATOR
Intervention: Placebo samples
Number of subjects: 0
Study 15129994 — intervention group
Group type: EXPERIMENTAL
Intervention: Urea-containing moisturisers
Number of subjects: 0
Study 15129994 — intervention group
Group type: COMPARATOR
Intervention: Placebo moisturisers
Number of subjects: 0
Study 15129994 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of SLS-irritated skin with urea and placebo
Number of subjects: 0
Study 11681814 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition (including n-3 Polyunsaturated fatty acids, glutamine, arginine, S amino acids, and nucleotides)
Number of subjects: 0
Study 11681814 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition (n-3 PUFA, glutamine, N-acetyl cysteine)
Number of subjects: 0
Study 11681814 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine and nucleotides
Number of subjects: 0
Study 11681814 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 10975536 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI pre-operative localization
Number of subjects: 24
Study 10975536 — intervention group
Group type: COMPARATOR
Intervention: CT pre-operative localization
Number of subjects: 24
Study 10975536 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI and CT
Number of subjects: 24
Study 8766083 — intervention group
Group type: EXPERIMENTAL
Intervention: M-VAC
Number of subjects: 60
Study 8766083 — intervention group
Group type: EXPERIMENTAL
Intervention: M-CAVI
Number of subjects: 60
Study 1433586 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (Cohen technique in 52% and Politano‐Leadbetter technique in 28%)
Number of subjects: 87
Study 1433586 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 87
Study 6149128 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg carvedilol (invasive study)
Number of subjects: 30
Study 6149128 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg carvedilol (non-invasive study)
Number of subjects: 30
Study 6149128 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg carvedilol (non-invasive study)
Number of subjects: 30
Study 6149128 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg carvedilol (all groups)
Number of subjects: 30
Study 31259819 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative MRI for flap tissue planning
Number of subjects: 62
Study 31259819 — intervention group
Group type: COMPARATOR
Intervention: External Doppler ultrasonography for flap planning
Number of subjects: 62
Study 31259819 — intervention group
Group type: COMPARATOR
Intervention: Comparison of flap raising times and cosmetic outcomes
Number of subjects: 62
Study 29326067 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 80
Study 29326067 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 80
Study 26727684 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative stoma marking by a certified wound, ostomy and continence nurse (CWOCN)
Number of subjects: 59
Study 26727684 — intervention group
Group type: COMPARATOR
Intervention: No preoperative stoma marking or preoperative ostomy education
Number of subjects: 59
Study 27366396 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (2 mg kg(‐1) infused over 10 min)
Number of subjects: 30
Study 27366396 — intervention group
Group type: COMPARATOR
Intervention: Control (50 mL saline infused over 10 min)
Number of subjects: 30
Study 22194590 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak expiratory flow (PEF) measurement with a pocket spirometer
Number of subjects: 5761
Study 22194590 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirometry for those with PEF < 70% predicted
Number of subjects: 5761
Study 22194590 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirometry for those with normal PEF
Number of subjects: 5761
Study 22194590 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factor analysis
Number of subjects: 5761
Study 22194590 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall screening
Number of subjects: 5761
Study 20575949 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar hemiarthroplasty
Number of subjects: 51
Study 20575949 — intervention group
Group type: COMPARATOR
Intervention: Unipolar hemiarthroplasty
Number of subjects: 51
Study 18051009 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (CP) bleaching agent - Opalescence
Number of subjects: 60
Study 18051009 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (CP) bleaching agent - Opalescence PF (3% potassium nitrate and 0.11% fluoride)
Number of subjects: 60
Study 18051009 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (CP) bleaching agent - Nite White Excel 3 (ACP)
Number of subjects: 60
Study 18051009 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (CP) bleaching agent - Opalescence + F (acidulated phosphate fluoride 1.23%)
Number of subjects: 60
Study 18051009 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (CP) bleaching agent - Opalescence PF + F
Number of subjects: 60
Study 18051009 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (CP) bleaching agent - Nite White Excel 3 + F
Number of subjects: 60
Study 16062097 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 15
Study 12404706 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (120 mg)
Number of subjects: 0
Study 12404706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10323378 — intervention group
Group type: EXPERIMENTAL
Intervention: Low insulin-ante-hypo (1.5 mU/min x kg)
Number of subjects: 30
Study 10323378 — intervention group
Group type: EXPERIMENTAL
Intervention: High insulin-ante-hypo (15.0 mU/min x kg)
Number of subjects: 30
Study 10323378 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antecedent hypoglycemia)
Number of subjects: 30
Study 8540928 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandoglobulin (SG) (0.5 g/kg/day)
Number of subjects: 34
Study 8540928 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentaglobin (PG) (5 mL/kg/day)
Number of subjects: 34
Study 8540928 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IVIG preparations (SG and PG)
Number of subjects: 34
Study 2185803 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant interferon alpha‐2a
Number of subjects: 60
Study 2185803 — intervention group
Group type: COMPARATOR
Intervention: medroxyprogesterone acetate
Number of subjects: 60